Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Ertapenem in Burn Patients
NCT01497990Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in bacterial infection, sponsored by CHU de Nantes. Primary endpoint: Serum concentrations of total ertapenem (Cmax, Vz, ClP, ClR, ClNR, fe, T1/2b, AUC0-alpha) at 24 hours. Started Jan 2010; status: completed.
02
Drugs
ertapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01497990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497990.